–
Stoke Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−86.1
FY22:
−104
FY23:
−115
FY24:
−101
FY25:
−20.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−85.1
FY22:
−103
FY23:
−112
FY24:
−99.2
FY25:
−18.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−85.8
FY22:
−101
FY23:
−105
FY24:
−89.0
FY25:
−6.89
(positive)
Change from FY21 to FY25
millions USD
FY21:
−85.8
FY22:
−101
FY23:
−105
FY24:
−89.0
FY25:
−6.89
All amounts in millions USD